SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 14, 2025 OWNERSHIP DOCUMENT
4 Jan 14, 2025 OWNERSHIP DOCUMENT
8-K Dec 10, 2024 FORM 8-K
4 Dec 5, 2024 OWNERSHIP DOCUMENT
4 Dec 5, 2024 OWNERSHIP DOCUMENT
4 Dec 5, 2024 OWNERSHIP DOCUMENT
8-K Nov 13, 2024 8-K
10-Q Nov 13, 2024 10-Q
SC 13G/A Nov 8, 2024 SELLAS LIFE SCIENCES GROUP, INC.
8-K Oct 4, 2024 FORM 8-K
8-K Aug 13, 2024 8-K
10-Q Aug 13, 2024 10-Q
8-K Aug 1, 2024 FORM 8-K
424B5 Aug 1, 2024 424B5
3 Jun 27, 2024 OWNERSHIP DOCUMENT
8-K Jun 21, 2024 FORM 8-K
8-K May 14, 2024 8-K
10-Q May 14, 2024 10-Q
EFFECT May 1, 2024
EFFECT May 1, 2024
ARS Apr 30, 2024 ARS
CORRESP Apr 29, 2024
CORRESP Apr 29, 2024
S-3/A Apr 29, 2024 S-3/A
DEFA14A Apr 29, 2024 DEFA14A
← Newer Page 4 of 51 · 1272 filings Older →